
R&D investments of the pharmaceutical company Chiesi 2015-2022
Between 2015 and 2022, the total amount of investments in research and development of the Italian pharmaceutical company Chiesi increased considerably. According to the data, indeed, expenses in this field went from 302 million euros in 2015 to over 589 million euros in 2021, the highest value registered in the period under consideration. This figure shows the worldwide R&D investments of the Italian pharmaceutical company Chiesi from 2015 to 2022.